Phebra
Manufacturing · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
19 Orion Rd, Lane Cove West, New South W...Phone Number
+61 294209199Website
www.phebra.comRevenue
$30.4 MillionIndustry
About Phebra
Phebra Org Chart
Is Phebra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Phebra is spiking on competitors!
Click to see if Phebra had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Phebra has new funding data
Product Launch: Get notified when Phebra launches new products
Congratulate Masked Content for being promoted to Masked Content at Phebra
Check if Phebra has recently received funding, and reach out quickly before it becomes old news!
Phebra, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Phebra recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Phebra
Compare insights from companies similar to Phebra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phebra is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Phebra is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Phebra.
Phebra Tech Stack
A closer look at the technologies used by Phebra
Most Recent Scoops
Phebra News & Media
BioSenic provides update regarding current license agreement with Phebra
INSIDE INFORMATIONMedsenic Partners With Phebra for the Clinical Development of the Oral Form of Arscimed® for the Treatment of Autoimmune Diseases
STRASBOURG, France--(BUSINESS WIRE)--Medsenic, a clinical-stage biopharmaceutical company focused on the discovery and development of novel indications and formulations of arsenic salts for the treatment of severe autoimmune diseases, announced today that it has entered into an exclusive licensing agreement with Australian company Phebra for the development of their patented OATO formulation (Oral Arsenic Trioxide) in the treatment of autoimmune diseases. This agreement is a major step in pavinMedsenic s’allie avec Phebra pour développer la forme orale d’Arscimed® dans le traitement de la maladie chronique du greffon contre l’hôte (cGvHD)
STRASBOURG, France--(BUSINESS WIRE)--Medsenic, société biopharmaceutique au stade clinique spécialisée dans la découverte et le développement de nouvelles indications et formulations de sels d'arsenic pour le traitement des maladies auto-immunes sévères, annonce aujourd’hui avoir passé un accord de licence avec la société australienne Phebra pour le développement de l’OATO (Oral Arsenic Trioxide) dans les maladies auto-immunes. Cet accord constitue une étape majeure pour préparer la mise sur leFinal Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic Leukaemia (APL) Confirm Bioequivalence of Oral and IV Formulations
SYDNEY, May 13, 2021 /PRNewswire/ -- Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference. The abstract builds on...
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phebra
Phebra is based in Sydney, Australia and offers a large range of sterile injectable pharmaceuticals, topical creams, and oral formulations such as tablets and suspensions.... Read More